(Q36937221)

17 August 2017

1 reference

title

Overviews of pathogen emergence: which pathogens emerge, when and why? (English)

1 reference

17 August 2017

Overviews of Pathogen Emergence: Which Pathogens Emerge, When and Why? (English)

0 references

author name string

S Cleaveland

1

1 reference

17 August 2017

D T Haydon

2

1 reference

17 August 2017

L Taylor

3

1 reference

17 August 2017

S. Cleaveland

1

0 references

D. T. Haydon

2

0 references

L. Taylor

3

0 references

publication date

1 January 2007

1 reference

Current Topics in Microbiology and Immunology

17 August 2017

2007

0 references

published in

1 reference

17 August 2017

volume

315

1 reference

17 August 2017

page(s)

85-111

1 reference

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

17 August 2017

cites work

1 reference

12 December 2020

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

1 reference

12 December 2020

Increased CD36 protein as a response to defective insulin signaling in macrophages

1 reference

12 December 2020

Ramipril and the development of diabetes.

1 reference

12 December 2020

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein

1 reference

12 December 2020

Effect of ramipril on the incidence of diabetes

1 reference

12 December 2020

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

12 December 2020

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

A reduced-glycemic load diet in the treatment of adolescent obesity.

1 reference

12 December 2020

Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Ph

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

PPARgamma and atherosclerosis

1 reference

12 December 2020

Binge drinking and mortality after acute myocardial infarction

1 reference

12 December 2020

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

1 reference

12 December 2020

Relationship of hyperinsulinemia to dietary intake in south Asian and European men.

1 reference

12 December 2020

Management of the metabolic syndrome-nicotinic acid

1 reference

12 December 2020

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data

1 reference

12 December 2020

Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).

1 reference

12 December 2020

Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds

1 reference

12 December 2020

Low prevalence of the metabolic syndrome in wine drinkers--is it the alcohol beverage or the lifestyle?

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Randomized trials of sodium reduction: an overview

1 reference

12 December 2020

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

1 reference

12 December 2020

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

1 reference

12 December 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

12 December 2020

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

12 December 2020

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

Dietary PUFA and the metabolic syndrome in Indian Asians living in the UK.

1 reference

12 December 2020

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

1 reference

12 December 2020

Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study

1 reference

12 December 2020

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

12 December 2020

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

The efficacy and safety of sibutramine for weight loss: a systematic review

1 reference

12 December 2020

Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view

1 reference

12 December 2020

Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome

1 reference

12 December 2020

Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men.

1 reference

12 December 2020

Effects of exercise and weight loss on cardiac risk factors associated with syndrome X.

1 reference

12 December 2020

Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

12 December 2020

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose

1 reference

12 December 2020

Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits

1 reference

12 December 2020

Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.

1 reference

12 December 2020

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

1 reference

12 December 2020

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

1 reference

12 December 2020

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

12 December 2020

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

1 reference

12 December 2020

Preventing type 2 diabetes mellitus.

1 reference

12 December 2020

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Cellular antioxidant effects of atorvastatin in vitro and in vivo

1 reference

12 December 2020

The metabolic syndrome: practical guide to origins and treatment: Part I.

1 reference

12 December 2020

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

1 reference

12 December 2020

Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress

1 reference

12 December 2020

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

12 December 2020

Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women.

1 reference

12 December 2020

Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

1 reference

12 December 2020

Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study

1 reference

12 December 2020

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?

1 reference

12 December 2020

Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study.

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Impact of dietary patterns and interventions on cardiovascular health

1 reference

12 December 2020

Dietary fat intake and the risk of coronary heart disease in women

1 reference

12 December 2020

The effects of diet on inflammation: emphasis on the metabolic syndrome

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Pathophysiology of dyslipidaemia in the metabolic syndrome

1 reference

12 December 2020

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

12 December 2020

Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome

1 reference

12 December 2020

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

12 December 2020

The use of fibrates and of statins in preventing atherosclerosis in diabetes

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

12 December 2020

Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

The metabolic syndrome

1 reference

12 December 2020

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

12 December 2020

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

10.1007/978-3-540-70962-6_5

Identifiers

DOI

0 references

PMC publication ID

7122528

0 references

1 reference